PLUS - 医索

找到约 86 条结果

A Phase 3, Randomized study of atezolizumab plus bevacizumab and chemotherapy in patients with EGFR or ALK mutated in non-small cell lung cancer (ATTLAS, KCSG-LU19-04)

医客学院

LBA17 Adjuvant abemaciclib plus endocrine therapy for HR , HER2-, high-risk early breast cancer Results from a preplanned monarchE overall survival interim analysis, including 5-year eff

医客学院 - 会议报告集

LBA74 Pembrolizumab plus chemotherapy vs chemotherapy as neoadjuvant and adjuvant therapy in locally-advanced gastric and gastroesophageal junction cancer The phase III KEYNOTE-585 stud

医客学院 - 医学PPT

Tislelizumab plus chemotherapy for patients with EGFR-mutated non-squamous non-small cell lung cancer who progressed on EGFR tyrosine kinase inhibitor therapy

医客学院 - 其他

slides-Efficacy_and_safety_of_lenvatinib_LEN_plus_pembrol

医客学院 - 会议报告集

posters-Sacituzumab_govitecan_SG_plus_enfortumab_vedotin_E

医客学院 - 会议报告集

posters-Realworld_study_of_chemotherapy_plus_immunotherapy

医客学院 - 会议报告集

posters-Efficacy_and_safety_of_nivolumab_plus_ipilimumab_N

医客学院 - 会议报告集

posters-Efficacy_and_safety_of_lenvatinib_LEN_plus_pembrol

医客学院 - 会议报告集

Tislelizumab plus chemotherapy versus pembrolizumab plus chemotherapy for the first-line treatment of advanced non-small cell lung cancer systematic review and indirect comparison of randomized trials

医客学院 - 药物说明

今日实时热搜